Tekla Capital Management LLC G1 Therapeutics, Inc. Transaction History
Tekla Capital Management LLC
- $2.53 Billion
- Q2 2023
A detailed history of Tekla Capital Management LLC transactions in G1 Therapeutics, Inc. stock. As of the latest transaction made, Tekla Capital Management LLC holds 423,869 shares of GTHX stock, worth $966,421. This represents 0.04% of its overall portfolio holdings.
Number of Shares
423,869
Previous 423,869
-0.0%
Holding current value
$966,421
Previous $1.14 Million
7.05%
% of portfolio
0.04%
Previous 0.04%
Shares
3 transactions
Others Institutions Holding GTHX
# of Institutions
95Shares Held
14.7MCall Options Held
631KPut Options Held
347K-
Vanguard Group Inc Valley Forge, PA2.08MShares$4.75 Million0.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA951KShares$2.17 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny904KShares$2.06 Million0.01% of portfolio
-
Raymond James & Associates St Petersburg, FL803KShares$1.83 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY785KShares$1.79 Million0.0% of portfolio
About G1 Therapeutics, Inc.
- Ticker GTHX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,746,800
- Market Cap $97.5M
- Description
- G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...